What is the current valuation of the US vitamin and mineral premixes market?

The market valuation was $782.83 Million in 2024. Read More

What is the projected market size for the US vitamin and mineral premixes market by 2035?

The market is projected to reach $1100.0 Million by 2035. Read More

What is the expected CAGR for the US vitamin and mineral premixes market during the forecast period 2025 - 2035?

The expected CAGR is 3.14% during the forecast period. Read More

Which application segment had the highest valuation in 2024?

The Food and Beverages segment had the highest valuation at $350.0 Million in 2024. Read More

What are the projected valuations for the Nutritional Supplements segment by 2035?

The Nutritional Supplements segment is projected to reach $380.0 Million by 2035. Read More

Which form of vitamin and mineral premixes is expected to dominate the market?

The Powder form is expected to dominate, with a projected valuation of $420.0 Million by 2035. Read More

What is the valuation range for the Minerals segment in 2024?

The Minerals segment had a valuation range of $250.0 Million to $350.0 Million in 2024. Read More

Which key players are leading the US vitamin and mineral premixes market?

Key players include BASF SE, DSM Nutritional Products, and Kemin Industries. Read More

What is the valuation range for the Livestock end-use segment in 2024?

The Livestock end-use segment had a valuation range of $200.0 Million to $300.0 Million in 2024. Read More

How does the projected growth of the Aquaculture segment compare to other end-use segments?

The Aquaculture segment is projected to reach $200.0 Million by 2035, which is lower than Livestock and Poultry segments. Read More

US Vitamin and Mineral Premixes Market

ID: MRFR/FnB/18017-HCR

100 Pages

Garvit Vyas

Last Updated: April 06, 2026

US Vitamin and Mineral Premixes Market Size, Share, Industry Trend & Analysis Research Report: By Application (Animal Feed, Food and Beverages, Nutritional Supplements, Pharmaceuticals), By Form (Powder, Liquid, Granular), By Nutritional Component (Vitamins, Minerals, Amino Acids, Trace Elements) andBy End Use (Livestock, Poultry, Aquaculture, Pet Food)- Forecast to 2035

US Vitamin and Mineral Premixes Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Animal Feed
  2. 4.1.2 Food and Beverages
  3. 4.1.3 Nutritional Supplements
  4. 4.1.4 Pharmaceuticals
2. 4.2 Pharmaceutical, BY Form (USD Million)
  1. 4.2.1 Powder
  2. 4.2.2 Liquid
  3. 4.2.3 Granular
3. 4.3 Pharmaceutical, BY Nutritional Component (USD Million)
  1. 4.3.1 Vitamins
  2. 4.3.2 Minerals
  3. 4.3.3 Amino Acids
  4. 4.3.4 Trace Elements
4. 4.4 Pharmaceutical, BY End Use (USD Million)
  1. 4.4.1 Livestock
  2. 4.4.2 Poultry
  3. 4.4.3 Aquaculture
  4. 4.4.4 Pet Food
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 DSM Nutritional Products (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Nutraceutical International Corporation (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Kemin Industries (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Archer Daniels Midland Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cargill, Incorporated (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 FMC Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Nutritional Solutions (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY FORM
4. 6.4 US MARKET ANALYSIS BY NUTRITIONAL COMPONENT
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY NUTRITIONAL COMPONENT, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY NUTRITIONAL COMPONENT, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY FORM, 2025-2035 (USD Million)
  3. 7.2.3 BY NUTRITIONAL COMPONENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Animal Feed
Food and Beverages
Nutritional Supplements
Pharmaceuticals

Pharmaceutical By Form (USD Million, 2025-2035)

Powder
Liquid
Granular

Pharmaceutical By Nutritional Component (USD Million, 2025-2035)

Vitamins
Minerals
Amino Acids
Trace Elements

Pharmaceutical By End Use (USD Million, 2025-2035)

Livestock
Poultry
Aquaculture
Pet Food

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”